A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease

Abroad (travel likely)Recruiting

Conditions

Tremor Associated With Tremor Dominant Parkinson's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Miami Neuroscience Institute Baptist Health, Miami, Florida, United States
Contact: Study coordinator (Justin Sporrer, MD) · JustinSp@baptisthealth.net · 786-596-2226
Contact: Study coordinator (Josette Elysée) · JosetteE@BaptistHealth.net · 786-596-1826
Contact: Principal Investigator (Justin Sporrer, MD)
Rush University, Chicago, Illinois, United States
Contact: Study coordinator (Edgar Y Perez) · Edgar_Y_Perez@rush.edu · 3129427391
Contact: Principal Investigator (Neepa Patel, MD)
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (John Rolston, MD, PhD) · jrolston@bwh.harvard.edu
Contact: Study coordinator (Anna Ball) · aball@bwh.harvard.edu
Contact: Principal Investigator (John Rolston, MD, PhD)
Weill Cornell Medicine, New York, New York, United States
Contact: Study coordinator (Michael Kaplitt, MD, PhD) · mik2002@med.cornell.edu
Contact: Study coordinator (Isabella Cipollone) · isc4005@med.cornell.edu · 203-917-9918
Contact: Principal Investigator (Michael Kaplitt, MD, PhD)
Novant Health Brain & Spine Surgery, Huntsville, North Carolina, United States
Contact: Study coordinator (Charles Munyon, MD) · cnmunyon@novanthealth.org
Contact: Study coordinator (Darren Crawford) · DarrenNCrawford@novanthealth.org
Contact: Principal Investigator (Charles Munyon, MD)
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Contact: Study coordinator (Courtney Cannon) · CANNONC2@ccf.org · 216-444-1057
Contact: Principal Investigator (Sean Nagel, MD)
Miami Valley Hospital, Fairborn, Ohio, United States
Contact: Study coordinator (Daniel Gaudin, MD) · dgaudin@premierhealth.com · 419-481-6220
Contact: Study coordinator (Heather Bell) · hrbell@premierhealth.com · 937-208-6013
Contact: Principal Investigator (Daniel Gaudin, MD)
University of Dundee, Dundee, Scotland, United Kingdom
Contact: Study coordinator (Tom Gilbertson, PhD MBBS) · t.gilbertson@dundee.ac.uk
Contact: Study coordinator (Kayleigh Anderson) · Kayleigh.anderson6@nhs.scot
Contact: Principal Investigator (Tom Gilbertson, PhD MBBS)

View source on ClinicalTrials.gov